Based on this pooled data analysis, adding recombinant human endostatin to radiotherapy or concurrent chemoradiotherapy is an effective and less toxic method for the treatment of patients with unresectable LA-NSCLC. Here, COL18A1 is linked to non-small cell lung carcinoma.